| Title |
Išsėtinės sklerozės gydymo ligos eigą modifikuojančiais vaistais rekomendacijos COVID-19 pandemijos metu / |
| Translation of Title |
Recommendations for the treatment of multiple sclerosis with disease-modifying drugs during the COVID-19 pandemic. |
| Authors |
Kizlaitienė, Rasa ; Giedraitienė, Nataša ; Sereikė, Ieva ; Liutkienė, Justina ; Leščinskienė, Loreta Meilutė ; Kaubrys, Gintaras Ferdinandas |
| DOI |
10.29014/ns.2020.13 |
| Full Text |
|
| Is Part of |
Neurologijos seminarai.. Vilnius : Rotas. 2020, t. 24, Nr. 2, p. 100-104.. ISSN 1392-3064. eISSN 2424-5917 |
| Keywords [eng] |
COVID-19 pandemic ; multiple sclerosis ; disease-modifying therapies |
| Abstract [eng] |
The novel coronavirus 2019 (COVID-19) and the subsequent pandemic present a challenge to neurologists treating patients with multiple sclerosis (MS) worldwide. Many national professional bodies have responded rapidly by issuing guidelines for the COVID-19 pandemic, primarily focused on MS disease-modifying therapies (DMTs). In this article, we review implications of COVID-19 for people with MS, including general health advice, the risk of respiratory infections, basic recommendations for relapse management, MS treatment, including disease-modifying therapies, and medical services for MS patients during the COVID-19 pandemic. |
| Published |
Vilnius : Rotas |
| Type |
Journal article |
| Language |
Lithuanian |
| Publication date |
2020 |
| CC license |
|
